XML 31 R25.htm IDEA: XBRL DOCUMENT
v2.4.0.8

NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS | 12 Months Ended
--- | ---
Jun. 30, 2014
Valuation and Qualifying Accounts [Abstract] |
NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS | NOTE 18 – ALLOWANCE FOR DOUBTFUL ACCOUNTS The following represents a summary of allowance for doubtful accounts for the years ended June 30, 2014 and 2013, respectively:
Description |  | Balance June 30, 2013 |  | Additions |  | Deductions |  | Balance June 30, 2014
Accounts receivable |  | $ | 257,362 |  |  | (1)$ | — |  |  | $ | — |  |  | $ | 257,362 |
Management and other fees receivable |  |  | 9,095,320 |  |  | (1) | 1,806,299 |  |  |  | — |  |  |  | 10,901,619 |
Management and other fees receivable - related medical practices |  |  | 403,047 |  |  |  | — |  |  |  | — |  |  |  | 403,047 |
Medical receivables |  |  | 2,584,669 |  |  | (1) | 10,333,082 |  |  |  | — |  |  |  | 12,917,751 |
Advance and notes to related parties |  |  | 202,379 |  |  |  | — |  |  |  | — |  |  |  | 202,379 |
Description |  | Balance June 30, 2012 |  | Additions |  | Deductions |  | Balance June 30, 2013
Accounts receivables |  | $ | 1,852,987 |  |  | (1)$ | (92,454 | ) |  | $ | 1,503,171 |  |  | $ | 257,362 |
Management and other fees receivable |  |  | 7,458,345 |  |  | (1) | 950,000 |  |  |  | — |  |  |  | 9,095,320 |
Management and other fees receivable - related medical practices |  |  | 403,047 |  |  |  | — |  |  |  | — |  |  |  | 403,047 |
Medical receivables |  |  | — |  |  | (1) | 2,584,669 |  |  |  |  |  |  |  | 2,584,669 |
Advance and notes to related parties |  |  | 239,791 |  |  |  | — |  |  |  | 37,412 |  |  |  | 202,379 |
Notes receivable |  |  | 65,000 |  |  |  | — |  |  |  | 65,000 |  |  |  | — |
(1) Included in provision for bad debts.

X
- Definition The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 09 -Article 12 + Details
Name: | us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ValuationAndQualifyingAccountsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration